|
KIF27 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.41335856748992E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.06949998751804E-09 |
| Normal-vs-Stage2 |
1.72809999998691E-06 |
| Normal-vs-Stage3 |
9.2139629259691E-12 |
| Normal-vs-Stage4 |
1.52460000180099E-09 |
| Stage1-vs-Stage2 |
6.179200E-01 |
| Stage1-vs-Stage3 |
6.762400E-02 |
| Stage1-vs-Stage4 |
7.605900E-02 |
| Stage2-vs-Stage3 |
4.803800E-01 |
| Stage2-vs-Stage4 |
3.121000E-01 |
| Stage3-vs-Stage4 |
5.870400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.35179645255334E-11 |
| Normal-vs-AfricanAmerican |
9.680200E-03 |
| Normal-vs-Asian |
3.36249999954852E-07 |
| Caucasian-vs-AfricanAmerican |
1.358620E-01 |
| Caucasian-vs-Asian |
9.409200E-01 |
| AfricanAmerican-vs-Asian |
2.668800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.31668067746705E-13 |
| Normal-vs-Female |
2.46019982164114E-10 |
| Male-vs-Female |
1.018650E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.00609997899915E-09 |
| Normal-vs-Age(41-60Yrs) |
1.5507000128423E-09 |
| Normal-vs-Age(61-80Yrs) |
7.03009872538018E-11 |
| Normal-vs-Age(81-100Yrs) |
6.2971999999939E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.847200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.814300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.634100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.842240E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.330560E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.791400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.585980E-02 |
| Classical-VS-Follicular |
4.335900E-02 |
| Classical-VS-Other |
2.766400E-01 |
| Classical-VS-Normal |
9.93980009411644E-10 |
| Tall-VS-Follicular |
5.419400E-01 |
| Tall-VS-Other |
9.161400E-01 |
| Tall-VS-Normal |
3.4241000035351E-09 |
| Follicular-VS-Other |
7.332600E-01 |
| Follicular-VS-Normal |
5.09800002213012E-09 |
| Other-VS-Normal |
1.936860E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.29110072527783E-11 |
| Normal-vs-N1 |
2.06989999995688E-06 |
| N0-vs-N1 |
6.278200E-01 |
|
|
